Active, not recruitingPhase 2NCT04577755
Pomalidomide Treatment in Patients With Kaposi Sarcoma
Studying Kaposi sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Samantha L VogtAIDS Malignancy Consortium
- Intervention
- Biopsy Procedure(procedure)
- Enrollment
- 45 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2026
Study locations (15)
- UC San Diego Moores Cancer Center, La Jolla, California, United States
- Miami Cancer Institute, Miami, Florida, United States
- University of Illinois, Chicago, Illinois, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
- Boston Medical Center, Boston, Massachusetts, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Mount Sinai Hospital, New York, New York, United States
- NYP/Weill Cornell Medical Center, New York, New York, United States
- Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
- University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States
- Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
- Thomas Street at Quentin Mease Health Center, Houston, Texas, United States
- M D Anderson Cancer Center, Houston, Texas, United States
- Virginia Mason Medical Center, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04577755 on ClinicalTrials.govOther trials for Kaposi sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06445166Propranolol for the Treatment of Kaposi Sarcoma in AdultsWashington University School of Medicine
- RECRUITINGNCT06751355Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility TrialWashington University School of Medicine
- RECRUITINGNCT06375122Natural History Study of Kaposi SarcomaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT04305691Trial of Ixazomib for Kaposi SarcomaAIDS Malignancy Consortium
- ACTIVE NOT RECRUITINGPHASE1NCT05646082Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi SarcomaImperial College London
- ACTIVE NOT RECRUITINGNANCT04742387Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal AnalysisNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT03993106A Study of sEphB4-HSA in Kaposi SarcomaVasgene Therapeutics, Inc
- RECRUITINGPHASE1, PHASE2NCT04303117PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi SarcomaNational Cancer Institute (NCI)